Brief: Nasdaq Grants VBI Vaccines That Co Has Until June 26, 2023, To Regain Compliance
30/12/2022 22:10
Dec 30 (Reuters) - VBI Vaccines Inc VBIV.O :
* VBI VACCINES - ON DEC 29, NASDAQ NOTIFIED CO HAS BEEN
GRANTED
ADDITIONAL 180-DAYS, UNTIL JUNE 26, 2023, TO REGAIN COMPLIANCE
WITH MINIMUM BID PRICE RULE
Source: (https://bit.ly/3Gv3032)
Further company coverage: VBIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55